Sangamo Therapeutics (SGMOQ) Shares Outstanding (Diluted) (2019 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Shares Outstanding (Diluted) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | 30.66 Mn |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | 96.51 Mn |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | 450.19 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | 184.32 Mn |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | 66.24 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | 104.33 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 413.69 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | 105.43 Mn |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | 52.31 Mn |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | 280.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 280.20 Mn |
| Sep 30, 2025 | 304.30 Mn |
| Jun 30, 2025 | 257.00 Mn |
| Mar 31, 2025 | 220.30 Mn |
| Dec 31, 2024 | 201.70 Mn |
| Sep 30, 2024 | 214.33 Mn |
| Jun 30, 2024 | 203.95 Mn |
| Mar 31, 2024 | 180.34 Mn |
| Dec 31, 2023 | 174.44 Mn |
| Sep 30, 2023 | 177.17 Mn |
| Jun 30, 2023 | 174.33 Mn |
| Mar 31, 2023 | 169.18 Mn |
| Dec 31, 2022 | 154.35 Mn |
| Sep 30, 2022 | 158.04 Mn |
| Jun 30, 2022 | 148.16 Mn |
| Mar 31, 2022 | 146.22 Mn |
| Dec 31, 2021 | 144.57 Mn |
| Sep 30, 2021 | 145.40 Mn |
| Jun 30, 2021 | 143.98 Mn |
| Mar 31, 2021 | 143.11 Mn |